Occupational exposures to human immunodeficiency virus, hepatitis B virus, and hepatitis C virus: risk, prevention, and management.
Current data indicate that the risk for transmitting bloodborne pathogens in dental health care settings is low. Pre-exposure hepatitis B vaccination and the use of standard precautions to prevent exposure to blood are the most effective strategies for preventing DHCP from occupational infection with HIV, HBV or HCV. Each dental health care facility should develop a comprehensive written program for preventing and managing occupational exposures to blood that: (1) describes the types of blood exposures that may place DHCP at risk for infection; (2) outlines procedures for promptly reporting and evaluating such exposures; and (3) identifies a health care professional who is qualified to provide counseling and perform all medical evaluations and procedures in accordance with the most current USPHS recommendations. Finally, resources should be available that permit rapid access to clinical care, testing, counseling, and PEP for exposed DHCP and the testing and counseling of source patients.
Cleveland
Jennifer L
JL
Division of Oral Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Mailstop F-10, 4770 Buford Highway, Chamblee, GA 30341, USA. jlcleveland@cdc.gov
Cardo
Denise M
DM
D019380:Anti-HIV Agents / Q000627:therapeutic use; D017848:Blood-Borne Pathogens; D003428:Cross Infection / Q000517:prevention & control; D003727:Dental Auxiliaries; D003815:Dentists; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D016174:Hepacivirus; D006509:Hepatitis B / Q000517:prevention & control* / Q000635:transmission; D006515:Hepatitis B virus; D006526:Hepatitis C / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D017758:Infectious Disease Transmission, Patient-to-Professional / Q000517:prevention & control; D016273:Occupational Exposure / Q000517:prevention & control*; D012307:Risk Factors
D019380:Anti-HIV Agents